mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
-0.14 |
0.01 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.01 |
mRNA |
erastin |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.01 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.01 |
mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.02 |
mRNA |
L-685458 |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.02 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.02 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.02 |
mRNA |
BMS-536924 |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.02 |
mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.02 |